Acinetobacter Infections, Bloodstream Infection, Enterococcus Faecium Infection, Escherichia Coli, Klebsiella Pneumonia, Pneumonia, Pseudomonas Aeruginosa, Skin Infection, Staphylococcus Aureus, Surgical Site Infection, Urinary Tract Infections
Conditions
Brief summary
The goal of this individual patient data meta-analysis is to estimate the attributed and the associated health burden related to bloodstream infections, pneumonia, skin and soft tissue infections, surgical site infections and urinary tract infections, caused by target drug-resistant pathogens, in high income countries. The main question\[s\] it aims to answer are: * Are common infections caused by drug-resistant pathogens associated with an increased health burden, when compared with individuals with the same infection caused by a susceptible strain (attributed burden)? * Are common infections caused by drug-resistant pathogens associated with an increase health burden, when compared with individuals without the infection under study (associated burden)?
Interventions
OTHERPathogen resistant phenotype
Drug resistant phenotype of the target pathogen under study
Sponsors
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Hospital Universitario Virgen Macarena
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Inclusion criteria
* Individuals of all ages * Individuals with hospital acquired, community acquired, or healthcare associated infections * Individuals treated at hospital level, community, or long-term care facilities * Individuals with the targeted pathogen, resistance phenotype, and infection site combinations under study
Exclusion criteria
* Individuals with infections in the following systems: central nervous system, genital system, pelvic infections and head and neck infections * Individuals with the following specific primary infections: endocarditis, upper respiratory tract infections, lung abscess * Individuals with bacterial infections not included in the table of pathogens of interest, polymicrobial infections except for intraabdominal infections, fungal infections, parasitic infections, viral infections, mycobacterial infections, sexually transmitted diseases, and zoonotic infections
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | Through study completion, an average of 1 year | Death any time after infection, during the follow-up time of the original study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with clinical cure | Through study completion, an average of 1 year | Absence of symptoms after completion of an antibiotic treatment course. |
| Number of participants with microbiological cure | Through study completion, an average of 1 year | No isolation of the causal microorganisms after completion of an antibiotic treatment course. |
| Number of participants with ICU admission | Through study completion, an average of 1 year | Need for an admission in ICU setting for more than 24 hours after infection onset. |
| Number of participants with superinfection | Through study completion, an average of 1 year | Other infections different from the one under assessment. |
| Number of participants with cognitive impairment / disability | Through study completion, an average of 1 year | Impairment is any temporal or permanent loss of function; disability is a restriction or inability to perform a normal activity resulting from an impairment. Assessed using Center for Epidemiologic Studies Depression Scale (CES-D), Mini-Mental State Examination (MMSE) or Trail Making Test (TMT). |
| Number of participants with recurrence of infection | Through study completion, an average of 1 year | Infection with the same organism after more than two weeks of the initial infection. |
Countries
Spain
Outcome results
None listed